Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elysse Dean

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Seminars in Thrombosis and Hemostasis|July 8, 2022
Evaluating Performance of Contemporary and Historical von Willebrand Factor (VWF) Assays in the Laboratory Identification of von Willebrand Disease (VWD): The Australasian ExperienceEmmanuel J Favaloro, Elysse Dean, Sandya Arunachalam
Seminars in Thrombosis and Hemostasis|November 15, 2023
Variable Performance of Lupus Anticoagulant Testing: The Australasian/Asia-Pacific ExperienceEmmanuel J Favaloro, Elysse Dean, Sandya Arunachalam
Seminars in Thrombosis and Hemostasis|March 1, 2024
Variable Performance of D-dimer Testing by Hemostasis Laboratories: The Australasian/Asia-Pacific ExperienceEmmanuel J Favaloro, Sandya Arunachalam, Elysse Dean
International Journal of Laboratory Hematology|April 21, 2024
Performance of direct oral anticoagulant (DOAC) testing by hemostasis laboratories: The Australasian/Asia-Pacific experienceEmmanuel J Favaloro, Sandya Arunachalam, Elysse Dean
Pathology|September 24, 2021
Evaluating errors in the laboratory identification of von Willebrand disease using contemporary von Willebrand factor assaysEmmanuel J Favaloro, Elysse Dean, Sandya Arunachalam, et al.
Clinical Chemistry and Laboratory Medicine|July 9, 2026
Systematic bias in point-of-care INR testing: comparative analysis of Abbott and Roche devicesSandya Arunachalam, Tony Badrick, Emmanuel J Favaloro, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 22, 2020
Reducing the effect of DOAC interference in laboratory testing for factor VIII and factor IX: A comparative study using DOAC Stop and andexanet alfa to neutralize rivaroxaban effectsEmmanuel J Favaloro, Grace Gilmore, Roslyn Bonar, et al.
Clinical Chemistry and Laboratory Medicine|March 4, 2020
Laboratory testing for activated protein C resistance: rivaroxaban induced interference and a comparative evaluation of andexanet alfa and DOAC Stop to neutralise interferenceEmmanuel J Favaloro, Grace Gilmore, Roslyn Bonar, et al.
International Journal of Laboratory Hematology|January 14, 2026
Performance of Factor VIII Extended Half-Life Product Measurements in External Quality Assessment ProgrammesAnna Williams, Piet Meijer, Elysse Dean, et al.
International Journal of Laboratory Hematology|February 19, 2025
Activated Protein C Resistance Testing: An Update From Australasia/Asia-PacificEmmanuel J Favaloro, Sandya Arunachalam, Elysse Dean, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Seminars in Thrombosis and Hemostasis|July 8, 2022
Evaluating Performance of Contemporary and Historical von Willebrand Factor (VWF) Assays in the Laboratory Identification of von Willebrand Disease (VWD): The Australasian ExperienceEmmanuel J Favaloro, Elysse Dean, Sandya Arunachalam
Seminars in Thrombosis and Hemostasis|November 15, 2023
Variable Performance of Lupus Anticoagulant Testing: The Australasian/Asia-Pacific ExperienceEmmanuel J Favaloro, Elysse Dean, Sandya Arunachalam
Seminars in Thrombosis and Hemostasis|March 1, 2024
Variable Performance of D-dimer Testing by Hemostasis Laboratories: The Australasian/Asia-Pacific ExperienceEmmanuel J Favaloro, Sandya Arunachalam, Elysse Dean
International Journal of Laboratory Hematology|April 21, 2024
Performance of direct oral anticoagulant (DOAC) testing by hemostasis laboratories: The Australasian/Asia-Pacific experienceEmmanuel J Favaloro, Sandya Arunachalam, Elysse Dean
Pathology|September 24, 2021
Evaluating errors in the laboratory identification of von Willebrand disease using contemporary von Willebrand factor assaysEmmanuel J Favaloro, Elysse Dean, Sandya Arunachalam, et al.
Clinical Chemistry and Laboratory Medicine|July 9, 2026
Systematic bias in point-of-care INR testing: comparative analysis of Abbott and Roche devicesSandya Arunachalam, Tony Badrick, Emmanuel J Favaloro, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 22, 2020
Reducing the effect of DOAC interference in laboratory testing for factor VIII and factor IX: A comparative study using DOAC Stop and andexanet alfa to neutralize rivaroxaban effectsEmmanuel J Favaloro, Grace Gilmore, Roslyn Bonar, et al.
Clinical Chemistry and Laboratory Medicine|March 4, 2020
Laboratory testing for activated protein C resistance: rivaroxaban induced interference and a comparative evaluation of andexanet alfa and DOAC Stop to neutralise interferenceEmmanuel J Favaloro, Grace Gilmore, Roslyn Bonar, et al.
International Journal of Laboratory Hematology|January 14, 2026
Performance of Factor VIII Extended Half-Life Product Measurements in External Quality Assessment ProgrammesAnna Williams, Piet Meijer, Elysse Dean, et al.
International Journal of Laboratory Hematology|February 19, 2025
Activated Protein C Resistance Testing: An Update From Australasia/Asia-PacificEmmanuel J Favaloro, Sandya Arunachalam, Elysse Dean, et al.
Pageof 2